SMS Pharmaceuticals Cash Flow
- Market cap
- ₹4,213 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹323.89 – ₹607.30
In the year ended FY25, SMS Pharmaceuticals generated ₹253 crore from operating activities, invested ₹169 crore and paid out ₹63.19 crore on financing activities. Net cash flow for the year was ₹21.06 crore. Free cash flow was ₹105 crore.
SMS Pharmaceuticals cash flow statement
Financial years, newest first. Negative figures are cash outflows.
| Item | FY25 |
|---|---|
| Cash from operating activities | 253 |
| Cash from investing activities | -169 |
| Cash from financing activities | -63.19 |
| Net cash flow | 21.06 |
| Capital expenditure | 147 |
| Free cash flow | 105 |
Source: Company filings, in ₹ crore. Data as of 9 October 2026. How this data is compiled.
SMS Pharmaceuticals cash flow — frequently asked questions
What is SMS Pharmaceuticals' operating cash flow?
SMS Pharmaceuticals' cash flow from operating activities was ₹253 crore in the year ended FY25.
What is SMS Pharmaceuticals' free cash flow?
SMS Pharmaceuticals' free cash flow — operating cash flow minus capital expenditure — was ₹105 crore in FY25, after capital expenditure of ₹147 crore.
How much did SMS Pharmaceuticals spend on investing activities?
Net cash used in investing activities was ₹169 crore in FY25. This covers capital expenditure, acquisitions and the purchase or sale of investments.
Same Data For Peers
Trade SMS Pharmaceuticals With ATS
Track SMSPHARMA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.